![Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial - The Lancet Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2092216225/2076440337/gr1.gif)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial - The Lancet
![Patrimonio inmaterial e intangible de la Industria. Artefactos, objetos, saberes y memoria de la industria - CICEES Patrimonio inmaterial e intangible de la Industria. Artefactos, objetos, saberes y memoria de la industria - CICEES](https://cicees.com/wp-content/uploads/2020/03/banner-suscripcion-menu.png)
Patrimonio inmaterial e intangible de la Industria. Artefactos, objetos, saberes y memoria de la industria - CICEES
![Switching Ratio from Parenteral to Oral Methadone 1:1.2 Is Safer Compared with Ratio 1:2 in Patients with Controlled Cancer Pain: A Multicenter Randomized-Controlled Trial (RATIOMTD-010810) | Journal of Palliative Medicine Switching Ratio from Parenteral to Oral Methadone 1:1.2 Is Safer Compared with Ratio 1:2 in Patients with Controlled Cancer Pain: A Multicenter Randomized-Controlled Trial (RATIOMTD-010810) | Journal of Palliative Medicine](https://www.liebertpub.com/cms/10.1089/jpm.2020.0244/asset/images/medium/jpm.2020.0244_figure1.jpg)
Switching Ratio from Parenteral to Oral Methadone 1:1.2 Is Safer Compared with Ratio 1:2 in Patients with Controlled Cancer Pain: A Multicenter Randomized-Controlled Trial (RATIOMTD-010810) | Journal of Palliative Medicine
![PDF) Prevalence and clinical characteristics of patients with Advanced Chronic Illness and Palliative Care needs, identified with the NECPAL CCOMS-ICO© Tool at a Tertiary Care Hospital PDF) Prevalence and clinical characteristics of patients with Advanced Chronic Illness and Palliative Care needs, identified with the NECPAL CCOMS-ICO© Tool at a Tertiary Care Hospital](https://i1.rgstatic.net/publication/365804025_Prevalence_and_clinical_characteristics_of_patients_with_Advanced_Chronic_Illness_and_Palliative_Care_needs_identified_with_the_NECPAL_CCOMS-ICOC_Tool_at_a_Tertiary_Care_Hospital/links/63855805c2cb154d293a135f/largepreview.png)
PDF) Prevalence and clinical characteristics of patients with Advanced Chronic Illness and Palliative Care needs, identified with the NECPAL CCOMS-ICO© Tool at a Tertiary Care Hospital
![Patrimonio inmaterial e intangible de la Industria. Artefactos, objetos, saberes y memoria de la industria - CICEES Patrimonio inmaterial e intangible de la Industria. Artefactos, objetos, saberes y memoria de la industria - CICEES](https://cicees.com/wp-content/uploads/2018/02/Los-ojos-de-la-memoria-12.jpg)
Patrimonio inmaterial e intangible de la Industria. Artefactos, objetos, saberes y memoria de la industria - CICEES
![G-1 compound could be used to fight obesity and diabetes – Studies in mice have shown that the G-1 compound reduces obesity and the effects of diabetes by burning extra calories, report G-1 compound could be used to fight obesity and diabetes – Studies in mice have shown that the G-1 compound reduces obesity and the effects of diabetes by burning extra calories, report](https://dp9bxf2pat5uz.cloudfront.net/wp-content/uploads/shutterstock_540949246.jpg)
G-1 compound could be used to fight obesity and diabetes – Studies in mice have shown that the G-1 compound reduces obesity and the effects of diabetes by burning extra calories, report
![Frontiers | Acute Effects of Salvia Supplementation on Cognitive Function in Athletes During a Fatiguing Cycling Exercise: A Randomized Cross-Over, Placebo-Controlled, and Double-Blind Study Frontiers | Acute Effects of Salvia Supplementation on Cognitive Function in Athletes During a Fatiguing Cycling Exercise: A Randomized Cross-Over, Placebo-Controlled, and Double-Blind Study](https://www.frontiersin.org/files/Articles/771518/fnut-08-771518-HTML-r1/image_m/fnut-08-771518-g001.jpg)